Thursday, July 21, 2022

This just in...A REPLY FROM SENATOR KIRSTEN GILLIBRAND

 

Dear Ms. Alexander,

Thank you for contacting me regarding prescription drug prices. I am deeply concerned about the continued increases to the costs of prescription drugs and believe pharmaceutical companies should be held accountable for putting profits over patients. It is unacceptable that too often patients are being forced to decide whether to buy food, pay their rent or pay for medication. I believe allowing Medicare to negotiate drug prices is an important step towards making prescription drugs more affordable to all, especially older adults and people with disabilities. 

I have heard from New Yorkers across the state regarding the challenges of high prescription drug costs, and I am fighting in the Senate for policies to address them. I support two bills that would reduce the cost of prescription drugs and make sure that everyone can access the medications they need. The first is The Medicare Drug Price Negotiation Act, which would allow the federal government to negotiate for lower prices for prescription drugs under Medicare Part D, with no changes to patient protections. Right now Medicare pays – on average – three times more than Medicaid for the same top-selling brand name drugs, simply because they are currently prohibited from negotiating. The other bill, the Affordable and Safe Prescription Drug Importation Act, would help level the market for Americans purchasing prescription drugs by allowing patients, pharmacists and wholesalers to import those lower-cost drugs from other countries. I will continue to work with my colleagues to address the continued rise of prescription drug prices. 

Thank you again for writing to express your concerns, and I hope that you keep in touch with my office in the future. For more information on this and other important issues, please visit my website at http://gillibrand.senate.gov

Sincerely,

Kirsten Gillibrand
United States Senator


No comments:

Post a Comment